Maplight Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$27.40

-1.80 (-6.16%)

As of May 9, 9:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +130.6% upside

Low Target $44.21

Average Target $63.19

High Target $83.67

Current Price $27.40

Current
$27.40

Target
$63.19

$44.21 $63.19 avg $83.67

Scenario Analysis

Bear Case

$44.21

61.4%

Low target

Base Case

$63.19

+130.6%

Avg target

Bull Case

$83.67

+205.4%

High target

Risk/Reward

3.3x

Highly favorable

Price in Context

52-Week High

$33.28

-17.7% from high

52-Week Low

$12.24

+123.9% from low

Target vs 52W High

$63.19

+89.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%